[Telemedicine from experimentation (ETAPES) to COVIDOM… a new era ?]

Ann Cardiol Angeiol (Paris). 2021 Nov;70(5):317-321. doi: 10.1016/j.ancard.2021.09.016. Epub 2021 Oct 7.
[Article in French]

Abstract

Telemedicine has been recognized since 2010 as a constitutive element of care, however, it was not until 2016 that the first national experiments were able to be launched with the aim of validating a framework allowing a possible rapid passage in the common right. These experiments, which are due to end in December 2021, have succeeded in involving more than 100,000 patients, mainly suffering from cardiac pathologies. The arrival of COVID-19 has made it possible to measure the usefulness of practices at a distance both from teleconsultation and telemonitoring, with the appearance of organizational and technical innovations that must now be maintained and developed in order to integrate the telemedicine of tomorrow into our actual medicine.

Keywords: COVID; care organisation; chronic heart failure; insuffisance cardiaque; organisation des soins; rythmologie; rythmology; telehealth; telemedicine; télécardiologie; télémédecine; télésanté.

MeSH terms

  • COVID-19 / epidemiology*
  • COVID-19 / therapy
  • Diabetes Mellitus / therapy
  • Heart Failure / therapy
  • Humans
  • Kidney Failure, Chronic / therapy
  • Pandemics*
  • Patient Satisfaction
  • Remote Consultation / methods
  • Remote Consultation / organization & administration
  • Respiratory Insufficiency / therapy
  • Telemedicine / economics
  • Telemedicine / organization & administration*
  • Telemedicine / trends